Journal article
Combination therapy for dyslipidemia
Abstract
PURPOSE OF REVIEW: Residual cardiovascular risk remains in individuals treated with statins and combination therapies may reduce this risk further.
RECENT FINDINGS: Most previous trials of combination therapies have shown a favorable effect on lipid profiles without clinical superiority over statin monotherapy. Trial design has been hampered by short duration and comparison with a low dose statin. The Study of Heart and Renal Protection trial …
Authors
Sharma M
Journal
Current Opinion in Cardiology, Vol. 26, No. 5, pp. 420–423
Publisher
Wolters Kluwer
Publication Date
September 2011
DOI
10.1097/hco.0b013e3283499ef1
ISSN
0268-4705